SRPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.70%

Insider Buying (Last 12 Months): $10,898,040.40

Insider Selling (Last 12 Months): $11,647,905.42

Sarepta Therapeutics Insider Trading History Chart

Sarepta Therapeutics Share Price & Price History

^$127.55

▲ +2.54 (2.03%)

As of 09/19/2024 01:46 PM ET

Days: 30 | 90 | 365

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Sarepta Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Ian Michael Estepan	CFO	Sell	5,985	$137.36	$822,099.60	33,946
8/16/2024	Michael Andrew Chambers	Director	Buy	37,038	$133.80	$4,955,684.40	284,034
6/25/2024	Ryan Edward Brown	EVP	Sell	38,957	$161.61	$6,295,840.77	17,129
6/24/2024	Bilal Arif	Insider	Sell	7,859	$163.08	$1,281,645.72	21,261
5/2/2024	Dallan Murray	Insider	Sell	3,635	$140.00	$508,900.00	18,125
3/11/2024	Kathryn Jean Boor	Director	Sell	761	$122.93	$93,549.73	7,516
3/8/2024	Hans Rudolf Wigzell	Director	Sell	15,000	$123.25	$1,848,750.00	22,840
3/5/2024	Stephen Mayo	Director	Sell	3,135	$122.96	$385,479.60	6,621
3/1/2024	Bilal Arif	Insider	Sell	2,000	$128.84	$257,680.00	26,836
3/1/2024	Ian Michael Estepan	CFO	Sell	1,200	$128.30	$153,960.00	39,114
11/3/2023	Douglas S. Ingram	CEO	Buy	25,225	$79.36	$2,001,856.00	390,307
11/3/2023	Richard Barry	Director	Buy	50,000	$78.81	$3,940,500.00	140,000
8/14/2023	Michael Andrew Chambers	Director	Buy	9,979	$109.47	$1,092,401.13	246,996
8/10/2023	Michael Andrew Chambers	Director	Buy	34,867	$106.15	$3,701,132.05	213,331
8/4/2023	Hans Rudolf Wigzell	Director	Sell	15,000	$106.72	$1,600,800.00	20,994
11/17/2022	Stephen Mayo	Director	Sell	858	$109.92	$94,311.36	6,387
9/14/2022	Michael Andrew Chambers	Director	Buy	57,100	$104.43	$5,962,953.00	108,178
8/19/2022	Michael Andrew Chambers	Director	Buy	46,170	$108.28	$4,999,287.60	51,078
11/24/2021	Louise Rodino-Klapac	Insider	Buy	3,780	$79.33	$299,867.40
11/17/2021	Douglas S. Ingram	CEO	Buy	25,026	$79.94	$2,000,578.44

This Crypto Is Set to Explode in September

From Crypto 101 Media | Ad

With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024.

Go here to get full details on this crypto now.

SEC Filings (Institutional Ownership Changes) for Sarepta Therapeutics (NASDAQ:SRPT)

86.68% of Sarepta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sarepta Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/27/2024	Clearbridge Investments LLC	237,354	$37.50M	0.0%	+57.0%	0.251%
8/26/2024	Teachers Retirement System of The State of Kentucky	30,200	$4.77M	0.0%	N/A	0.032%
8/22/2024	Cetera Investment Advisers	13,013	$2.06M	0.0%	+8.5%	0.014%
8/21/2024	Advisory Alpha LLC	1,320	$0.21M	0.0%	-50.9%	0.001%
8/21/2024	Truist Financial Corp	4,003	$0.63M	0.0%	+86.5%	0.004%
8/19/2024	Point72 Asset Management L.P.	48,913	$7.73M	0.0%	-99.7%	0.052%
8/19/2024	EP Wealth Advisors LLC	4,899	$0.77M	0.0%	+2.1%	0.005%
8/16/2024	Northwestern Mutual Wealth Management Co.	250	$40K	0.0%	-87.8%	0.000%
8/16/2024	NewEdge Advisors LLC	5,591	$0.88M	0.0%	-19.6%	0.006%
8/16/2024	Creative Planning	7,937	$1.25M	0.0%	+11.7%	0.008%
8/16/2024	Algert Global LLC	62,552	$9.88M	0.3%	+1.3%	0.066%
8/15/2024	Lighthouse Investment Partners LLC	50,342	$7.95M	0.3%	N/A	0.053%
8/15/2024	Mackenzie Financial Corp	61,261	$9.68M	0.0%	+68.2%	0.065%
8/15/2024	The Manufacturers Life Insurance Company	89,525	$14.15M	0.0%	+121.7%	0.095%
8/15/2024	Point72 Hong Kong Ltd	6,756	$1.07M	0.1%	N/A	0.007%
8/14/2024	Fred Alger Management LLC	318,252	$50.28M	0.2%	+23.6%	0.337%
8/14/2024	Marshall Wace LLP	43,335	$6.85M	0.0%	+1,196.3%	0.046%
8/14/2024	Xponance Inc.	18,546	$2.93M	0.0%	+62.1%	0.020%
8/14/2024	Evergreen Capital Management LLC	1,323	$0.21M	0.0%	N/A	0.001%
8/14/2024	Avoro Capital Advisors LLC	3,000,000	$474M	6.3%	-30.9%	3.174%
8/14/2024	Ally Bridge Group NY LLC	73,500	$11.61M	6.9%	N/A	0.078%
8/14/2024	HighVista Strategies LLC	2,364	$0.37M	0.1%	N/A	0.003%
8/14/2024	ProShare Advisors LLC	10,286	$1.63M	0.0%	+56.4%	0.011%
8/14/2024	Profund Advisors LLC	28,297	$4.47M	0.2%	+153.4%	0.030%
8/13/2024	Evolutionary Tree Capital Management LLC	20,963	$3.31M	3.4%	-19.5%	0.022%
8/13/2024	Ensign Peak Advisors Inc	225,328	$35.60M	0.1%	+20.3%	0.238%
8/13/2024	Nkcfo LLC	275	$43K	0.0%	N/A	0.000%
8/13/2024	Ameritas Investment Partners Inc.	20,105	$3.18M	0.2%	N/A	0.021%
8/13/2024	Thrivent Financial for Lutherans	644,675	$101.86M	0.2%	+6.3%	0.682%
8/13/2024	Sei Investments Co.	13,964	$2.21M	0.0%	-77.3%	0.015%
8/13/2024	Pacer Advisors Inc.	14,998	$2.37M	0.0%	+4,259.9%	0.016%
8/13/2024	Simplify Asset Management Inc.	104,536	$16.52M	1.1%	+15.5%	0.111%
8/13/2024	Canada Pension Plan Investment Board	230,300	$36.39M	0.0%	-4.2%	0.244%
8/13/2024	Public Employees Retirement Association of Colorado	9,066	$1.43M	0.0%	-9.5%	0.010%
8/12/2024	XTX Topco Ltd	4,578	$0.72M	0.1%	N/A	0.005%
8/12/2024	Optimist Retirement Group LLC	1,391	$0.22M	0.1%	N/A	0.001%
8/12/2024	Seven Eight Capital LP	24,684	$3.90M	0.4%	+198.2%	0.026%
8/12/2024	Hsbc Holdings PLC	2,358	$0.37M	0.0%	-95.3%	0.002%
8/12/2024	Blair William & Co. IL	174,282	$27.54M	0.1%	+303.7%	0.184%
8/12/2024	Vanguard Personalized Indexing Management LLC	4,505	$0.71M	0.0%	+11.9%	0.005%
8/12/2024	Amalgamated Bank	48,721	$7.70M	0.1%	+724.7%	0.052%
8/12/2024	Meiji Yasuda Asset Management Co Ltd.	2,396	$0.38M	0.0%	N/A	0.003%
8/12/2024	Mercer Global Advisors Inc. ADV	5,621	$0.89M	0.0%	+40.8%	0.006%
8/12/2024	E Fund Management Co. Ltd.	8,761	$1.38M	0.1%	+151.4%	0.009%
8/10/2024	Mutual of America Capital Management LLC	54,121	$8.55M	0.1%	N/A	0.057%
8/10/2024	Sofinnova Investments Inc.	195,852	$30.95M	1.6%	-13.9%	0.207%
8/9/2024	Renaissance Technologies LLC	352,000	$55.62M	0.1%	-9.8%	0.372%
8/9/2024	Dimensional Fund Advisors LP	255,396	$40.35M	0.0%	+13.9%	0.270%
8/9/2024	Prime Capital Investment Advisors LLC	8,405	$1.33M	0.0%	-29.8%	0.009%
8/9/2024	WINTON GROUP Ltd	2,688	$0.43M	0.0%	N/A	0.003%
8/8/2024	Envestnet Asset Management Inc.	68,679	$10.85M	0.0%	+69.1%	0.073%
8/8/2024	Oppenheimer Asset Management Inc.	4,312	$0.68M	0.0%	+19.6%	0.005%
8/8/2024	Westover Capital Advisors LLC	2,625	$0.42M	0.1%	N/A	0.003%
8/8/2024	Federated Hermes Inc.	508,329	$80.32M	0.2%	-16.7%	0.538%
8/8/2024	Meeder Asset Management Inc.	525	$83K	0.0%	+1,490.9%	0.001%
8/8/2024	First Turn Management LLC	181,669	$28.70M	4.7%	-18.1%	0.192%
8/8/2024	Thornburg Investment Management Inc.	40,182	$6.35M	0.1%	+10.8%	0.043%
8/8/2024	American Century Companies Inc.	7,184	$1.14M	0.0%	+14.1%	0.008%
8/8/2024	State of New Jersey Common Pension Fund D	32,940	$5.21M	0.0%	-35.9%	0.035%
8/7/2024	Daiwa Securities Group Inc.	3,454	$0.55M	0.0%	+28.7%	0.004%
8/7/2024	Texas Permanent School Fund Corp	21,022	$3.32M	0.0%	N/A	0.022%
8/7/2024	PFG Investments LLC	24,529	$3.88M	0.3%	+1.8%	0.026%
8/6/2024	Emerald Advisers LLC	4,279	$0.68M	0.0%	+130.9%	0.005%
8/6/2024	Acadian Asset Management LLC	8,566	$1.35M	0.0%	N/A	0.009%
8/6/2024	New Mexico Educational Retirement Board	19,200	$3.03M	0.1%	N/A	0.020%
8/5/2024	Arizona State Retirement System	23,647	$3.74M	0.0%	+2.2%	0.025%
8/5/2024	Victory Capital Management Inc.	83,073	$13.13M	0.0%	+15.4%	0.088%
8/3/2024	National Bank of Canada FI	7,527	$1.18M	0.0%	+5.2%	0.008%
8/3/2024	TD Asset Management Inc	159,082	$25.14M	0.0%	-9.9%	0.168%
8/2/2024	Ferguson Shapiro LLC	1,444	$0.23M	0.1%	N/A	0.002%
8/2/2024	Oregon Public Employees Retirement Fund	19,600	$3.10M	0.1%	N/A	0.021%
8/1/2024	Fiera Capital Corp	382,645	$60.46M	0.2%	+4.3%	0.405%
8/1/2024	Rhumbline Advisers	270,941	$42.81M	0.0%	+146.3%	0.287%
8/1/2024	CIBC Asset Management Inc	2,626	$0.42M	0.0%	+13.7%	0.003%
8/1/2024	Guidance Capital Inc.	1,877	$0.30M	0.1%	-6.6%	0.002%
8/1/2024	Natixis Advisors LLC	12,137	$1.92M	0.0%	N/A	0.013%
8/1/2024	AM Squared Ltd	200	$32K	0.1%	-66.7%	0.000%
7/31/2024	nVerses Capital LLC	2,200	$0.35M	0.2%	+340.0%	0.002%
7/31/2024	Mizuho Markets Americas LLC	326,300	$51.56M	1.2%	+12.2%	0.345%
7/31/2024	Van ECK Associates Corp	83,106	$13.13M	0.0%	-3.7%	0.088%
7/31/2024	MUFG Securities EMEA plc	37,900	$5.99M	0.3%	N/A	0.040%
7/30/2024	Pinnacle Associates Ltd.	50,115	$7.92M	0.1%	-44.5%	0.053%
7/30/2024	Maryland State Retirement & Pension System	7,055	$1.12M	0.0%	+6.0%	0.007%
7/30/2024	Forum Financial Management LP	1,680	$0.27M	0.0%	N/A	0.002%
7/30/2024	Signaturefd LLC	10,751	$1.70M	0.0%	+1,228.9%	0.011%
7/29/2024	Crossmark Global Holdings Inc.	6,167	$0.98M	0.0%	N/A	0.007%
7/29/2024	Peregrine Capital Management LLC	36,294	$5.73M	0.2%	+2.2%	0.038%
7/29/2024	Braun Stacey Associates Inc.	98,185	$15.51M	0.5%	N/A	0.104%
7/29/2024	Principal Financial Group Inc.	363,011	$57.36M	0.0%	+693.7%	0.384%
7/29/2024	Innealta Capital LLC	196	$31K	0.0%	N/A	0.000%
7/29/2024	Tobam	49,183	$7.77M	1.2%	-59.0%	0.052%
7/29/2024	Riggs Asset Managment Co. Inc.	300	$47K	0.0%	+33.3%	0.000%
7/26/2024	Cambridge Investment Research Advisors Inc.	6,331	$1M	0.0%	+1.9%	0.007%
7/26/2024	Allspring Global Investments Holdings LLC	21,777	$3.44M	0.0%	-91.7%	0.023%
7/26/2024	State of Michigan Retirement System	22,800	$3.60M	0.0%	N/A	0.024%
7/26/2024	AlphaCentric Advisors LLC	7,500	$1.19M	0.9%	+2,688.1%	0.008%
7/26/2024	EFG Asset Management North America Corp.	26,603	$4.20M	0.7%	-7.7%	0.028%
7/25/2024	Silvant Capital Management LLC	25,059	$3.96M	0.2%	+58.2%	0.027%
7/25/2024	Bank Pictet & Cie Europe AG	2,214	$0.35M	0.0%	N/A	0.002%
7/25/2024	Banque Pictet & Cie SA	34,524	$5.46M	0.0%	N/A	0.037%

Data available starting January 2016

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $127.55

$125.78

$128.65

50 Day Range

MA: $138.26

$124.33

$152.67

52 Week Range

Now: $127.55

$55.25

$173.25

Volume

203,440 shs

Average Volume

1,303,514 shs

Market Capitalization

$12.06 billion

P/E Ratio

1,159.55

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Sarepta Therapeutics?: Sarepta Therapeutics' top insider investors include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Dallan Murray (Insider)
Ryan Edward Brown (EVP)
Kathryn Jean Boor (Director)
Stephen Mayo (Director)
Learn More about top insider investors at Sarepta Therapeutics.
Who are the major institutional investors of Sarepta Therapeutics?: Sarepta Therapeutics' top institutional shareholders include:
Avoro Capital Advisors LLC — 3.17%
Susquehanna International Group LLP — 0.00%
Thrivent Financial for Lutherans — 0.68%
Federated Hermes Inc. — 0.54%
Fiera Capital Corp — 0.40%
Principal Financial Group Inc. — 0.38%
Learn More about top institutional investors of Sarepta Therapeutics stock.
Which institutional investors are selling Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was sold by these institutional investors:
Point72 Asset Management L.P.
Avoro Capital Advisors LLC
Allspring Global Investments Holdings LLC
Federated Hermes Inc.
Assenagon Asset Management S.A.
Tobam
Hsbc Holdings PLC
Sei Investments Co.
During the previous year, company insiders that have sold Sarepta Therapeutics company stock include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Dallan Murray (Insider)
Learn More investors selling Sarepta Therapeutics stock.
Which institutional investors are buying Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was bought by institutional investors including:
Susquehanna International Group LLP
Principal Financial Group Inc.
Rhumbline Advisers
Blair William & Co. IL
Retirement Systems of Alabama
Braun Stacey Associates Inc.
Clearbridge Investments LLC
New York State Teachers Retirement System
Within the last year, these company insiders have bought Sarepta Therapeutics stock:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Learn More investors buying Sarepta Therapeutics stock.